Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Consolidated Net Profit

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Consolidated Net Profit ₹1,282 Cr₹1,433 Cr₹127 Cr₹10,304 Cr₹579 Cr

What is the latest Consolidated Net Profit of MANKIND PHARMA ?

The latest Consolidated Net Profit ratio of MANKIND PHARMA is ₹1,282 Cr based on Mar2024 Consolidated results.
Year Consolidated Net Profit
Mar2024₹1,282 Cr
Mar2023₹1,433 Cr
Mar2022₹127 Cr
Mar2021₹10,304 Cr
Mar2020₹579 Cr

How is Consolidated Net Profit of MANKIND PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2024 ₹1,282 Cr
-10.58
Mar2023 ₹1,433 Cr
1,032.80
Mar2022 ₹127 Cr
-98.77
Mar2021 ₹10,304 Cr
1,681.10
Mar2020 ₹579 Cr -

Compare Consolidated Net Profit of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹101,363.4 Cr 2.4% 7.1% 3.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,155.0 Cr -3.9% 3% 7.9% Stock Analytics
DIVIS LABORATORIES ₹147,295.0 Cr -5% -1.1% 71.6% Stock Analytics
CIPLA ₹116,664.0 Cr -4.4% 0.2% -1.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹107,678.0 Cr -1.6% 6.5% 26.2% Stock Analytics
DR REDDYS LABORATORIES ₹96,162.6 Cr -2.4% 2.4% -5.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

2.4%

7.1%

3.9%

SENSEX

-2.5%

1.9%

4.9%


You may also like the below Video Courses